Literature DB >> 11135724

Perioperative activation of hemostasis in vascular surgery patients.

C M Samama1, D Thiry, I Elalamy, M Diaby, J J Guillosson, E Kieffer, P Coriat.   

Abstract

BACKGROUND: Perioperative activation of hemostasis could play an important role in the occurrence of postoperative cardiac events. The authors conducted a prospective study to assess platelet function, coagulation, and fibrinolysis status during and after infrarenal aortic surgery.
METHODS: Seventeen patients were studied. Excluded were patients with preoperative coagulopathies or liver disease, or cardiac or renal insufficiency; patients receiving anticoagulant treatment, antiplatelet agents, nonsteroidal antiinflammatory agents, fresh frozen plasma, or platelet concentrates; and patients undergoing reoperation and septic patients. Blood samples were drawn before induction (T1), 1 h after incision (T2), 1 h after extubation (T3), 24 h postoperatively (T4), 48 h postoperatively (T5), and at day 7 (T6). The following tests were performed: platelet count, platelet aggregation, platelet flow cytometry for CD62 and CD63, usual coagulation tests, thrombin--antithrombin complexes, plasminogen activator inhibitor 1.
RESULTS: A significant increase of adenosine diphosphate--induced platelet aggregation was observed postoperatively at T4 and T5. This was not associated with a change of flow cytometry profile. No increase of thrombin--antithrombin complex levels was observed. A higher fibrinogen rate was detected at T5 and T6. Greater amounts of plasminogen activator inhibitor 1 were detected at T3 and T4. Thus, thrombin generation was limited and fibrinolysis was impaired postoperatively. Platelets were not activated in the postoperative period, as shown by flow cytometry, but were prone to be activated, as shown by aggregation studies.
CONCLUSION: The association of more easily activated platelets with a higher fibrinogen rate and a temporary shut down of fibrinolysis during the early postoperative period may indicate an increased thrombotic risk in patients undergoing major vascular surgery.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11135724     DOI: 10.1097/00000542-200101000-00015

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  14 in total

Review 1.  [Current aspects of anesthetic management in urological patients].

Authors:  O Groll; J Peters
Journal:  Urologe A       Date:  2010-09       Impact factor: 0.639

2.  Platelet hyperreactivity in response to on- and off-pump coronary artery bypass grafting.

Authors:  Louise Bochsen; Lisbeth Bredahl Rosengaard; Allan Bybeck Nielsen; Daniel A Steinbrüchel; Pär I Johansson
Journal:  J Extra Corpor Technol       Date:  2009-03

3.  [Perioperative management of patients with coronary stents in non-cardiac surgery].

Authors:  J Jambor; M Spannagl; B Zwissler
Journal:  Anaesthesist       Date:  2010-02       Impact factor: 1.041

4.  Is preoperative withdrawal of aspirin necessary in patients undergoing elective inguinal hernia repair?

Authors:  Wilson Ong; Tong Shen; Wee Boon Tan; Davide Lomanto
Journal:  Surg Endosc       Date:  2016-04-29       Impact factor: 4.584

5.  A randomised controlled pilot trial to evaluate and optimize the use of anti-platelet agents in the perioperative management in patients undergoing general and abdominal surgery--the APAP trial (ISRCTN45810007).

Authors:  D Antolovic; A Rakow; P Contin; A Ulrich; N N Rahbari; M W Büchler; J Weitz; M Koch
Journal:  Langenbecks Arch Surg       Date:  2011-11-03       Impact factor: 3.445

6.  Patient with recent coronary artery stent requiring major non cardiac surgery.

Authors:  Usha Kiran; Neeti Makhija
Journal:  Indian J Anaesth       Date:  2009-10

Review 7.  [Perioperative management of patients with coronary stents in non-cardiac surgery].

Authors:  C Jámbor; M Spannagl; B Zwissler
Journal:  Anaesthesist       Date:  2009-10       Impact factor: 1.041

8.  Platelet aggregation and coagulation factors in orthopedic surgery.

Authors:  Brandon S Oberweis; Germaine Cuff; Andrew Rosenberg; Luis Pardo; Michael A Nardi; Yu Guo; Ezra Dweck; Mitchell Marshall; David Steiger; Steven Stuchin; Jeffrey S Berger
Journal:  J Thromb Thrombolysis       Date:  2014-11       Impact factor: 2.300

9.  [Drug-eluting stents: implications for surgery patients].

Authors:  S Bölükbas; J Jähne; J Schirren
Journal:  Chirurg       Date:  2009-06       Impact factor: 0.955

10.  Platelet activation increases in patients undergoing vascular surgery.

Authors:  Gabriel S Schneider; Caron B Rockman; Jeffrey S Berger
Journal:  Thromb Res       Date:  2014-08-23       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.